Recent reports in parts of the U.S. and Europe suggest a rare and potentially fatal inflammatory disease linked to #coronavirus is afflicting a small number of children. #Leronlimab may be able to help calm #CytokineStorm
Condition resembles a rare childhood illness called #KawasakiDisease, which has similar signs and symptoms and can lead to enlargement of blood vessels that in severe forms may cause heart damage. #Leronlimab has shown to help calm #CytokineStorm and maybe good #treatment
Dr. Bruce Patterson: “Cytokines are proteins that modulate the inflammatory response. #KawasakiDisease has been shown to be associated w elevated levels of RANTES, a protein shown to be significantly elevated in mild-moderate #COVID19." #Leronlimab
Nader Pourhassan, Ph.D.: We hope our comprehensive cytokine testing will help Drs. gain a better understanding of the disease process & explore the prospect of #Leronlimab to provide a therapeutic benefit to children suffering from inflammatory illness related to #COVID19
$CYDY #leronlimab blocks the binding of RANTES to immune cells, preventing mass migration of cells causing damage & the release of proteins causing cytokine storm; it restores the immunosuppressant, taking CD8 cells back to normal. Then it knocked the viral load to 0 in 14 days
$CYDY After seeing results from 100s of patients over weeks of therapy, Dr. Patterson is optimistic. He has observed that #leronlimab may make #COVID a viral disease instead of an immunological disease if administered early, & if administered later, it can repair virus damage.